报 告 人：Prof. Nigel S. Scrutton, Director of the Manchester Institute of Biotechnology (MIB) at the University of Manchester, UK.
报告题目: Enzyme Catalysis and Chemicals Production: New Insights that Interconnect Quantum Biology, Biocatalysis and Synthetic Biology.
报告时间：10月12日 11:00
报告地点：天津工业生物所 B301 阶梯教室
报告人简介
Nigel Scrutton is Director of the Manchester Institute of Biotechnology (MIB) at the University of Manchester, UK. He is responsible for the strategic leadership and operational management of the institute, which comprises over 50 leading research groups (ca 500 research staff) from across all Faculties and is home to ca £100M of current grant funding and 8 spin out companies. Nigel gained his PhD (1988; as a Benefactors' Scholar) and ScD (2003) at the University of Cambridge where he was awarded the Henry Humphrey's Research Prize. At Cambridge he held a Royal Society University Research Fellowship, a Royal Commission for the Exhibition of 1851 Fellowship and college fellowships. He was appointed Professor at the University of Manchester in 2005, where he held a BBSRC Professorial Research Fellowship and was Research Dean prior to his appointment as MIB Director. He also held academic positions (1995-2005) at the University of Leicester UK prior to taking up his current position at Manchester. He currently holds an EPSRC senior fellowship.
Nigel has an established position in the field of enzyme catalysis, biophysics and biomolecular engineering. He is recipient of the Biochemical Society Colworth Medal, the RSC Charmian Medal, the RSC Rita and John Cornforth Award and a Royal Society Wolfson Research Merit Award. He has served on several national steering groups, advisory boards and governing bodies. He heads a group of ca 40 researchers. He has published ca 380 scientific papers, holds several patents, and has edited 3 volumes on enzyme chemistry, quantum biology, biocatalysis, synthetic biology and engineering. He has held contiguous externally funded research fellowships for 29 years. Nigel is Director of the BBSRC/EPSRC Synthetic Biology Research Centre 'SYNBIOCHEM' based in MIB and Director of a Marie Curie IDP 'MAGIC' responsible for the training of 12 early stage researchers at Manchester. Nigel is also a Director of the MIB spin out company C3 Biotechnologies Ltd. He holds visiting professorships at Tsinghua University, China and University of Cardiff, UK.
Nigel’s group is noted internationally for its contributions to enzyme catalysis, especially in the fields of quantum biology (tunneling), protein dynamics and biocatalysis, and more recently synthetic biology in relation to chemicals production. His work is interdisciplinary at the interfaces of chemistry, biology and physics, supported by a genuinely world-leading infrastructure for biophysical chemistry that he has established at Manchester.
新闻简讯（链接）
海报
